美国退伍军人的阻塞性呼吸道疾病:流行率,特征和健康负担
Patricia M Bamonti1, Ian Fischer2, Jennifer Moye3
1Research & Development, VA Boston Healthcare System, 150 S. Huntington Avenue, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, 2 West, Room 305, 401 Park Drive, Boston, MA, 02215, USA.
Journal of psychiatric research
|June 10, 2024
概括
阻塞性呼吸道疾病在美国退伍军人中很常见,并且与增加心理健康状况的风险有关,如PTSD,抑郁症,焦虑症和自杀念头.
科学领域:
- 公共卫生 公共卫生
- 退伍军人健康 退伍军人的健康
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘和COPD等阻塞性呼吸道疾病 (ORD) 显著影响退伍军人的健康.
- 了解同时发生的心理和身体健康负担对于这个人群至关重要.
研究的目的:
- 调查与美国退伍军人的阻塞性呼吸道疾病相关的精神和身体健康负担.
- 确定与退伍军人的ORD相关的特定心理健康状况和身体健康特征.
主要方法:
- 2019-2020年全国退伍军人健康和弹性研究的二次数据分析.
- 对自我报告ORD的退伍军人进行比较 (n=502) 与对照 (n=3169) 的健康特征.
- 多变量回归分析以确定独立的关联.
主要成果:
- 12.5%的退伍军人报告了阻塞性呼吸道疾病的诊断.
- 患有ORD的退伍军人患上创伤后压力,严重抑郁症,泛性焦虑症和自杀念头的几率更高.
- 在ORD的退伍军人中观察到,终身尼古丁使用障碍,医疗并发症和体征症状的患病率增加.
结论:
- 阻塞性呼吸道疾病在美国退伍军人中普遍存在,并承担着相当大的心理和身体健康负担.
- 对于ORD退伍军人的并发性精神病和医疗状况,有必要进行综合查和治疗.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Other Pulmonary Disorders
827
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
827
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


